Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 1
2021 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Current advances in the clinical development of anti-tubercular agents.
Tetali SR, Kunapaeddi E, Mailavaram RP, Singh V, Borah P, Deb PK, Venugopala KN, Hourani W, Tekade RK. Tetali SR, et al. Among authors: hourani w. Tuberculosis (Edinb). 2020 Dec;125:101989. doi: 10.1016/j.tube.2020.101989. Epub 2020 Sep 5. Tuberculosis (Edinb). 2020. PMID: 32957054 Review.
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives.
Venugopala KN, Al-Shar'i NA, Dahabiyeh LA, Hourani W, Deb PK, Pillay M, Abu-Irmaileh B, Bustanji Y, Chandrashekharappa S, Tratrat C, Attimarad M, Nair AB, Sreeharsha N, Shinu P, Haroun M, Kandeel M, Balgoname AA, Venugopala R, Morsy MA. Venugopala KN, et al. Among authors: hourani w. Antibiotics (Basel). 2022 Jun 21;11(7):831. doi: 10.3390/antibiotics11070831. Antibiotics (Basel). 2022. PMID: 35884084 Free PMC article.
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
Venugopala KN, Chandrashekharappa S, Deb PK, Tratrat C, Pillay M, Chopra D, Al-Shar'i NA, Hourani W, Dahabiyeh LA, Borah P, Nagdeve RD, Nayak SK, Padmashali B, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Haroun M, Shashikanth S, Mohanlall V, Mailavaram R. Venugopala KN, et al. Among authors: hourani w. J Enzyme Inhib Med Chem. 2021 Dec;36(1):1472-1487. doi: 10.1080/14756366.2021.1919889. J Enzyme Inhib Med Chem. 2021. PMID: 34210233 Free PMC article.
Mass spectrometry-based metabolomics approach and in vitro assays revealed promising role of 2,3-dihydroquinazolin-4(1H)-one derivatives against colorectal cancer cell lines.
Dahabiyeh LA, Hudaib F, Hourani W, Darwish W, Abu-Irmaileh B, Deb PK, Venugopala KN, Mohanlall V, Chandrashekharappa S, Abu-Dahab R, Semreen MH, Bustanji Y. Dahabiyeh LA, et al. Among authors: hourani w. Eur J Pharm Sci. 2023 Mar 1;182:106378. doi: 10.1016/j.ejps.2023.106378. Epub 2023 Jan 11. Eur J Pharm Sci. 2023. PMID: 36638899 Free article.